ATE416790T1 - Wasserlösliche trockene zusammensetzungen - Google Patents

Wasserlösliche trockene zusammensetzungen

Info

Publication number
ATE416790T1
ATE416790T1 AT99926788T AT99926788T ATE416790T1 AT E416790 T1 ATE416790 T1 AT E416790T1 AT 99926788 T AT99926788 T AT 99926788T AT 99926788 T AT99926788 T AT 99926788T AT E416790 T1 ATE416790 T1 AT E416790T1
Authority
AT
Austria
Prior art keywords
dry compositions
water soluble
amino acids
hydrophobic amino
defoaming agents
Prior art date
Application number
AT99926788T
Other languages
English (en)
Inventor
Chikamasa Yamashita
Masaaki Odomi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of ATE416790T1 publication Critical patent/ATE416790T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99926788T 1998-06-26 1999-06-24 Wasserlösliche trockene zusammensetzungen ATE416790T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18079698 1998-06-26

Publications (1)

Publication Number Publication Date
ATE416790T1 true ATE416790T1 (de) 2008-12-15

Family

ID=16089500

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99926788T ATE416790T1 (de) 1998-06-26 1999-06-24 Wasserlösliche trockene zusammensetzungen

Country Status (14)

Country Link
US (2) US6337067B1 (de)
EP (1) EP1018345B1 (de)
JP (1) JP4332694B2 (de)
KR (1) KR100652943B1 (de)
CN (1) CN100341575C (de)
AT (1) ATE416790T1 (de)
AU (1) AU760940B2 (de)
CA (1) CA2301889C (de)
DE (1) DE69940051D1 (de)
DK (1) DK1018345T3 (de)
ES (1) ES2317695T3 (de)
ID (1) ID24279A (de)
PT (1) PT1018345E (de)
WO (1) WO2000000221A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7758794B2 (en) 2001-10-29 2010-07-20 Princeton University Method of making an article comprising nanoscale patterns with reduced edge roughness
AU784885B2 (en) * 1999-12-24 2006-07-20 Otsuka Pharmaceutical Co., Ltd. Dry compositions containing hydrophobic amino acid
TWI232102B (en) * 2001-07-17 2005-05-11 Shionogi & Co A pharmaceutical formulation for injection
JP4610154B2 (ja) * 2002-05-30 2011-01-12 大塚製薬株式会社 注射用製剤
FR2857267B1 (fr) * 2003-07-09 2006-03-10 Lab Francais Du Fractionnement Formulation stabilisante et solubilisante pour les proteines cryoprecipitables.
US20100217664A1 (en) * 2007-09-07 2010-08-26 Ryan Steelberg Engine, system and method for enhancing the value of advertisements
EP2236520A1 (de) * 2009-03-31 2010-10-06 Leukocare Ag Stabilisierungszusammensetzung für immobilisierte Biomoleküle
DK2533791T3 (en) * 2009-12-21 2017-05-08 Glanbia Nutritionals (Ireland) Ltd LEUCIN-PEPTID COMPOSITION AND PROCEDURE FOR FORMULATION
PE20191242A1 (es) 2011-10-25 2019-09-16 Prothena Biosciences Ltd Formulaciones de anticuerpo y metodos
JP2022065647A (ja) * 2020-10-15 2022-04-27 三栄源エフ・エフ・アイ株式会社 配糖体含有製剤、及び配糖体含有組成物の泡立ち抑制方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0168008A3 (de) 1984-07-10 1986-12-30 Takeda Chemical Industries, Ltd. Stabile Gamma-Interferonzusammensetzung
DE4242863A1 (de) * 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Stabile lyophilisierte pharmazeutische Zubereitungen von G-CSF
CN1045390C (zh) * 1994-06-16 1999-10-06 谭灿文 复合氨基酸冲剂
TW403653B (en) * 1995-12-25 2000-09-01 Otsuka Pharma Co Ltd Dry compositions

Also Published As

Publication number Publication date
CA2301889C (en) 2008-02-19
CN100341575C (zh) 2007-10-10
ID24279A (id) 2000-07-13
US20010049361A1 (en) 2001-12-06
US6479048B2 (en) 2002-11-12
CA2301889A1 (en) 2000-01-06
CN1272795A (zh) 2000-11-08
WO2000000221A1 (en) 2000-01-06
JP4332694B2 (ja) 2009-09-16
AU4392899A (en) 2000-01-17
ES2317695T3 (es) 2009-04-16
HK1028738A1 (en) 2001-03-02
EP1018345A4 (de) 2005-01-26
PT1018345E (pt) 2009-01-23
US6337067B1 (en) 2002-01-08
DE69940051D1 (de) 2009-01-22
KR100652943B1 (ko) 2006-12-01
WO2000000221A9 (en) 2000-07-27
DK1018345T3 (da) 2009-03-23
KR20010023269A (ko) 2001-03-26
EP1018345A1 (de) 2000-07-12
AU760940B2 (en) 2003-05-22
EP1018345B1 (de) 2008-12-10

Similar Documents

Publication Publication Date Title
AU4549989A (en) Aqueous ophthalmic solutions and method for preserving same
CA2198004A1 (en) Rinse aid for plasticware
ES2041965T3 (es) Emulsiones silaniocas tamponadas para impartir propiedades hidrofobas en sustratos porosos.
CA2209048A1 (en) Aqueous curable alkoxy silane/alkoxy silylated polymer compositions with extended shelf life
ATE93678T1 (de) Mikrobiozide jodzusammensetzung.
ATE416790T1 (de) Wasserlösliche trockene zusammensetzungen
WO2002026277A3 (en) Stabilized hydrogen peroxide solutions
DE69102900D1 (de) Brausemischung, deren Herstellung sowie Verwendung.
GR3003622T3 (de)
ES2124063T3 (es) Composiciones de microemulsiones de compuestos de 3-isotiazolonas.
KR970006224A (ko) 시멘트 조성물
FR2790953B1 (fr) Composition a phase aqueuse continue renfermant de l'acide l-2-oxothiazolidine 4-carboxylique
ATE335409T1 (de) Suesstoffzusammensetzung
DE69114635D1 (de) 1,3-Diphenyl-2-propin-1-one.
WO2003048342A3 (en) Liquid yeast compositions
ATE205386T1 (de) Einphasige,transparente wässrige zusammensetzung
GB9522885D0 (en) Improvements in or relating to organic compositions
NO985219L (no) Stabilisert og bufret hydrogenperoksydoppl°sning, dens fremstilling og anvendelse ved dekontaminering av kontaktlinser
IT1273616B (it) Composizioni acquose termoreattive a base di dispersioni o soluzioni poliuretaniche stabili
NO943373D0 (no) Psyliumholdig sammensatt blandingsdrikk
FR2732354B1 (fr) Composition a recurer se presentant sous forme liquide ou de creme
BE900030A (fr) Compositions fongicides synergiques.
RU98109064A (ru) Глазные пленки
ES2126015T3 (es) Uso de etofibrato y composiciones farmaceuticas que contienen etofibrato para el tratamiento de la angiopatia y la retinopatia diabeticas.
FI930358A0 (fi) Vattenhaltiga polymeratpreparat

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1018345

Country of ref document: EP